U.S. flag

An official website of the United States government

NM_001243133.2(NLRP3):c.2176A>G (p.Ser726Gly) AND Autoinflammatory syndrome

Germline classification:
Likely benign (1 submission)
Last evaluated:
Jan 1, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002262814.3

Allele description [Variation Report for NM_001243133.2(NLRP3):c.2176A>G (p.Ser726Gly)]

NM_001243133.2(NLRP3):c.2176A>G (p.Ser726Gly)

Gene:
NLRP3:NLR family pyrin domain containing 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q44
Genomic location:
Preferred name:
NM_001243133.2(NLRP3):c.2176A>G (p.Ser726Gly)
HGVS:
  • NC_000001.11:g.247429610A>G
  • NG_007509.2:g.18438A>G
  • NM_001079821.3:c.2176A>G
  • NM_001127461.3:c.2176A>G
  • NM_001127462.3:c.2150+4011A>G
  • NM_001243133.2:c.2176A>GMANE SELECT
  • NM_004895.5:c.2182A>G
  • NM_183395.3:c.2150+4011A>G
  • NP_001073289.1:p.Ser728Gly
  • NP_001073289.2:p.Ser726Gly
  • NP_001120933.2:p.Ser726Gly
  • NP_001230062.1:p.Ser726Gly
  • NP_004886.3:p.Ser728Gly
  • NP_004886.3:p.Ser728Gly
  • LRG_197t1:c.2182A>G
  • LRG_197:g.18438A>G
  • LRG_197p1:p.Ser728Gly
  • NC_000001.10:g.247592912A>G
  • NM_001079821.2:c.2182A>G
  • NM_001127462.2:c.2156+4011A>G
  • NM_004895.4:c.2182A>G
  • p.S728G
  • p.Ser728Gly
Protein change:
S726G
Links:
dbSNP: rs147946775
NCBI 1000 Genomes Browser:
rs147946775
Molecular consequence:
  • NM_001127462.3:c.2150+4011A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_183395.3:c.2150+4011A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001079821.3:c.2176A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127461.3:c.2176A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001243133.2:c.2176A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004895.5:c.2182A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Autoinflammatory syndrome
Identifiers:
MONDO: MONDO:0019751; MedGen: C3890737

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002542616Genome Diagnostics Laboratory, The Hospital for Sick Children
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely benign
(Jan 1, 2020)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Genome Diagnostics Laboratory, The Hospital for Sick Children, SCV002542616.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024